- Home
- CNSP vs ACON Comparison
CNSP vs ACON Comparison
Compare CNSP & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- ACON
- Stock Information
- Founded
- CNSP 2017
- ACON 2008
- Country
- CNSP United States
- ACON United States
- Employees
- CNSP N/A
- ACON N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- CNSP Health Care
- ACON Technology
- Exchange
- CNSP Nasdaq
- ACON Nasdaq
- Market Cap
- CNSP 5.6M
- ACON 4.5M
- IPO Year
- CNSP 2019
- ACON 2022
- Fundamental
- Price
- CNSP $8.82
- ACON $7.47
- Analyst Decision
- CNSP Hold
- ACON Buy
- Analyst Count
- CNSP 1
- ACON 2
- Target Price
- CNSP N/A
- ACON $481.00
- AVG Volume (30 Days)
- CNSP 27.0K
- ACON 13.2K
- Earning Date
- CNSP 08-13-2025
- ACON 08-13-2025
- Dividend Yield
- CNSP N/A
- ACON N/A
- EPS Growth
- CNSP N/A
- ACON N/A
- EPS
- CNSP N/A
- ACON N/A
- Revenue
- CNSP N/A
- ACON $54,601.00
- Revenue This Year
- CNSP N/A
- ACON $145.39
- Revenue Next Year
- CNSP N/A
- ACON $145.45
- P/E Ratio
- CNSP N/A
- ACON N/A
- Revenue Growth
- CNSP N/A
- ACON N/A
- 52 Week Low
- CNSP $7.72
- ACON $6.20
- 52 Week High
- CNSP $744.00
- ACON $3,499.51
- Technical
- Relative Strength Index (RSI)
- CNSP 37.72
- ACON 49.34
- Support Level
- CNSP $7.72
- ACON $7.12
- Resistance Level
- CNSP $9.62
- ACON $7.60
- Average True Range (ATR)
- CNSP 0.86
- ACON 0.35
- MACD
- CNSP -0.13
- ACON 0.04
- Stochastic Oscillator
- CNSP 29.99
- ACON 55.72
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.